BenfoTeam Study for Alzheimer’s Disease
A Seamless Phase 2A-Phase 2B Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients with Early Alzheimer’s Disease (BENFO-TEAM)
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase II
- Conditions Being Studied: Brain and Nervous System, Alzheimers Disease
Study Purpose
The purpose of this study is to evaluate an investigational drug called Benfotiamine (study drug) as a possible treatment for Alzheimer’s disease.
Who Can Participate
Participants 50 years and older diagnosed with Alzheimer’s disease be eligible for this study. To learn more about this study, please fill out the form below to request more information or learn more at Benfoteam.org.
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: N/A
- StudyID: 2023-01352
- ClinicalTrials.gov: N/A
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422